These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16784978)

  • 1. CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival.
    Deschamps L; Handra-Luca A; O'Toole D; Sauvanet A; Ruszniewski P; Belghiti J; Bedossa P; Couvelard A
    Hum Pathol; 2006 Jul; 37(7):802-8. PubMed ID: 16784978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression.
    Chang MC; Xiao S; Nosé V
    Hum Pathol; 2007 May; 38(5):732-40. PubMed ID: 17306326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
    Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
    Fleischmann A; Schlomm T; Huland H; Köllermann J; Simon P; Mirlacher M; Salomon G; Chun FH; Steuber T; Simon R; Sauter G; Graefen M; Erbersdobler A
    Clin Cancer Res; 2008 Dec; 14(23):7838-42. PubMed ID: 19047112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours.
    Pelosi G; Pasini F; Bresaola E; Bogina G; Pederzoli P; Biolo S; Menard S; Zamboni G
    J Pathol; 1997 Sep; 183(1):62-9. PubMed ID: 9370949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
    Srivastava A; Alexander J; Lomakin I; Dayal Y
    Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
    Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
    Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors.
    Takahashi Y; Akishima-Fukasawa Y; Kobayashi N; Sano T; Kosuge T; Nimura Y; Kanai Y; Hiraoka N
    Clin Cancer Res; 2007 Jan; 13(1):187-96. PubMed ID: 17200354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis.
    Abdou AG
    APMIS; 2007 Nov; 115(11):1206-18. PubMed ID: 18092952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity in pancreatic endocrine tumors.
    Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
    Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
    Chu P; Arber DA
    Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
    La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
    Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenoma.
    Handra-Luca A; Fléjou JF; Rufat P; Corcos O; Belghiti J; Ruszniewski P; Degott C; Bedossa P; Couvelard A
    Histopathology; 2006 Jun; 48(7):813-21. PubMed ID: 16722930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
    Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
    Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.